Related Experiment Video
Updated: Dec 15, 2025
07:08
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
1.2K
Treatment sequencing for pancreatic neuroendocrine tumors: daring to challenge the status quo
Callisia N Clarke1, Douglas B Evans2
1Assistant Professor of Surgery, Division of Surgical Oncology, Medical College of Wisconsin, Milwaukee, WI, USA. (Email: cnclarke@mcw.edu).
Journal of Gastrointestinal Oncology
|July 14, 2020
Abstract
No abstract available in PubMed .
Related Concept Videos
01:29Chronic Pancreatitis II: Collaborative Care
206
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
206
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
430
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
430